Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.48 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11323690 | 0.76 | HTR6 (0.55) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL565121 | 0.76 | HTR6 (0.55) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL28841908 | 0.72 | ALDH1A1 (0.52) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL5166440 | 0.72 | HTR6 (0.50) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL15434593 | 0.72 | HTR6 (0.50) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL11335316 | 0.72 | HTR6 (0.50) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL31452871 | 0.70 | HTR6 (0.55) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL576427 | 0.70 | HTR6 (0.55) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL31452872 | 0.70 | HTR6 (0.55) | DUSP3PTPN5PTPN11HTR6ALDH1A1 | |
| SCHEMBL135257 | 0.70 | DNMT1 (0.56) | DUSP3PTPN5PTPN11HTR6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103113387-B | The synthetic method of asymmetric two thieno-heteroaromatic compounds | HENAN UNIVERSITY (CN) | 2016-02-17 | — | — | CN | claimed |
| CN-103113387-B | The synthetic method of asymmetric two thieno-heteroaromatic compounds | HENAN UNIVERSITY (CN) | 2016-02-17 | — | — | CN | disclosed |
| CN-103113387-B | The synthetic method of asymmetric two thieno-heteroaromatic compounds | HENAN UNIVERSITY (CN) | 2016-02-17 | — | — | CN | disclosed |
| CN-103113387-A | Synthesis method of asymmetrical dithieno heteroaromatic compounds | UNIV HENAN | 2013-05-22 | — | — | CN | disclosed |
| CN-103113387-A | Synthesis method of asymmetrical dithieno heteroaromatic compounds | UNIV HENAN | 2013-05-22 | — | — | CN | disclosed |
| EP-0880540-B1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | AVENTIS PHARMA INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6365597-B1 | FOR THERAPY OF ANDROGEN AND ESTROGEN MEDIATED DISORDERS, INCLUDING BENIGN PROSTATIC HYPERPLASIA, ANDROGEN MEDIATED PROSTATE CANCER, ESTROGEN MEDIATED BREAST CANCER AND ACNE | AVENTIS PHARMACEUTICALS INC. | 2002-04-02 | — | — | US | disclosed |
| EP-0880540-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997030069-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-21 | — | — | WO | disclosed |